2024-12-28 18:59:54
First Patient Dosed in Phase II 'IPAX-Linz' Study of TLX101 for Glioblastoma Therapy
Corporate/ 2023-07-24
First Patient Dosed in Phase II 'IP...

MELBOURNE,Australia,Nov. 22,2022--Telix Pharmaceuticals Limited (ASX: TLX,Telix,the Company)today announces that a first patient has been do...

3Z: Zebrafish mutant model reveals novel drug candidates for ADHD
Health/ 2023-07-22
3Z: Zebrafish mutant model reveals novel...

REYKJAVIK,Iceland,Nov. 22,2022-- ADHD is a highly prevalent neurodevelopmental disorder. The first-line therapeutic for ADHD,methylphenidate...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release